rs870856

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001481.3(DRC4):​c.3+331C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.317 in 152,052 control chromosomes in the GnomAD database, including 7,805 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 7805 hom., cov: 32)

Consequence

DRC4
NM_001481.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.02

Publications

10 publications found
Variant links:
Genes affected
DRC4 (HGNC:4166): (growth arrest specific 8) This gene includes 11 exons spanning 25 kb and maps to a region of chromosome 16 that is sometimes deleted in breast and prostrate cancer. The second intron contains an apparently intronless gene, C16orf3, that is transcribed in the opposite orientation. This gene is a putative tumor suppressor gene. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]
DRC4 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 33
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, PanelApp Australia
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 16-90023055-C-G is Benign according to our data. Variant chr16-90023055-C-G is described in ClinVar as Benign. ClinVar VariationId is 1222931.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.405 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DRC4NM_001481.3 linkc.3+331C>G intron_variant Intron 1 of 10 ENST00000268699.9 NP_001472.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GAS8ENST00000268699.9 linkc.3+331C>G intron_variant Intron 1 of 10 1 NM_001481.3 ENSP00000268699.4

Frequencies

GnomAD3 genomes
AF:
0.317
AC:
48209
AN:
151932
Hom.:
7791
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.327
Gnomad AMI
AF:
0.385
Gnomad AMR
AF:
0.332
Gnomad ASJ
AF:
0.221
Gnomad EAS
AF:
0.197
Gnomad SAS
AF:
0.421
Gnomad FIN
AF:
0.278
Gnomad MID
AF:
0.361
Gnomad NFE
AF:
0.319
Gnomad OTH
AF:
0.340
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.317
AC:
48254
AN:
152052
Hom.:
7805
Cov.:
32
AF XY:
0.317
AC XY:
23559
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.327
AC:
13566
AN:
41486
American (AMR)
AF:
0.332
AC:
5074
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.221
AC:
767
AN:
3470
East Asian (EAS)
AF:
0.197
AC:
1013
AN:
5144
South Asian (SAS)
AF:
0.420
AC:
2019
AN:
4810
European-Finnish (FIN)
AF:
0.278
AC:
2939
AN:
10586
Middle Eastern (MID)
AF:
0.367
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
0.319
AC:
21696
AN:
67942
Other (OTH)
AF:
0.341
AC:
721
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1647
3294
4940
6587
8234
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
494
988
1482
1976
2470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.316
Hom.:
951
Bravo
AF:
0.315
Asia WGS
AF:
0.315
AC:
1094
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.70
DANN
Benign
0.79
PhyloP100
-2.0
PromoterAI
0.058
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs870856; hg19: chr16-90089463; API